PartecipaSalute, an Italian project to involve lay people, patients’ associations and scientific‐medical representatives in the health debate

Consumers and patients are increasingly demanding an active role in health-care access and quality, and associations and pressure groups are interacting directly with national health services and with researchers, doctors and scientific or professional societies. This article describes an Italian project aimed at creating a partnership among lay people, patients associations and the scientific/medical community. In Italy, consumers are generally passive recipients of health information from various sources: doctors and health-care professionals, the health system, media, web and parents or peers. This information is often contradictory and non-evidence-based, leading to misunderstandings and confusion. The Di Bella case, the outcry about an alleged new cure for autism, and the increasing number of health awareness campaigns are all clear examples of the lack of an evidence-based culture among Italian consumers and patients associations (see Box 1). To cope with this, lay people must learn how to develop their scientific literacy, becoming familiar with clinical and epidemiological research and acquiring instruments to critically appraise and understand health information. Although these activities are in their infancy in Italy, there are some good examples of empowerment efforts (see Box 2). The number of consumer and patients associations is steadily growing: a survey in 2003 by the Italian National Statistical Institute identified about 21 000 non-profit organizations across the country, a 50% increase compared with a 1997 survey. These organizations cover a wide spectrum of activities corresponding to a broad definition of health, including psychosocial support and direct services, and the findings confirm the deeply rooted Italian tradition of mutual aid in the health-care field. In the last 10 years, consumers and patients associations have extended their interventions from self-help and care to advocacy, including important efforts to convey more information to the public, and organize awareness raising campaigns. In common with other European and American countries, patients federations are emerging in Italy to boost the impact of individual organizations. Some now lobby at local, national and international level, drawing health authorities attention to the need for improvement in a given area. This has led to the introduction of patients charters and the mandatory presence of lay representatives on local ethics committees, yet the medical and scientific community still fails to see patients and consumer groups as partners with equal rights and weight . Consumers, patients and their associations, on the other hand, often lack doi: 10.1111/j.1369-7625.2007.00444.x

[1]  R. Moynihan,et al.  The Fight against Disease Mongering: Generating Knowledge for Action , 2006, PLoS medicine.

[2]  K. Dickersin,et al.  Development and implementation of a science training course for breast cancer activists: Project LEAD (leadership, education and advocacy development) , 2001, Health expectations : an international journal of public participation in health care and health policy.

[3]  D. Collyar,et al.  How have patient advocates in the United States benefited cancer research? , 2005, Nature Reviews Cancer.

[4]  K. Dickersin,et al.  Quantitative impact of including consumers in the scientific review of breast cancer research proposals. , 2002, Journal of women's health & gender-based medicine.

[5]  E. Buiatti,et al.  Results from a historical survey of the survival of cancer patients given Di Bella Multitherapy , 1999, Cancer.

[6]  P. Tugwell,et al.  Consumer‐driven health care: Building partnerships in research , 2005, Health expectations : an international journal of public participation in health care and health policy.

[7]  Andrew Herxheimer,et al.  Relationships between the pharmaceutical industry and patients' organisations , 2003, BMJ : British Medical Journal.

[8]  N. Magrini,et al.  The Di Bella multitherapy trial , 1999, BMJ.

[9]  P. Mosconi,et al.  Italian forum of Europa Donna: a survey of breast cancer associations , 1999, Health expectations : an international journal of public participation in health care and health policy.

[10]  M. Mayer From access to evidence: an advocate's journey. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  P. Mosconi Industry funding of patients' support groups: Declaration of competing interests is rare in Italian breast cancer associations , 2003, BMJ : British Medical Journal.

[12]  M. Ferriter,et al.  Gluten- and casein-free diets for autistic spectrum disorder. , 2019, The Cochrane database of systematic reviews.

[13]  K. Abbasi Di Bella's cure declared ineffective , 1998 .

[14]  J. Scadding,et al.  The James Lind Alliance: patients and clinicians should jointly identify their priorities for clinical trials , 2004, The Lancet.

[15]  J. Bunders,et al.  Patients’ priorities concerning health research: the case of asthma and COPD research in the Netherlands , 2005, Health expectations : an international journal of public participation in health care and health policy.

[16]  EUROPA DONNA: has strength in its heterogeneity. , 2004, European journal of cancer.

[17]  J. Boote,et al.  What does it mean to involve consumers successfully in NHS research? A consensus study , 2004, Health expectations : an international journal of public participation in health care and health policy.

[18]  Evaluation of an unconventional cancer treatment (the Di Bella multitherapy): results of phase II trials in Italy , 1999, BMJ.